Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Avontec, Biotronik develop drug-coated stents

Executive Summary

Two companies focusing on vascular intervention, Avontec GMBH and medical device firm Biotronik GMBH & Co., are collaborating to develop and market a second-generation drug-eluting stent based on Biotronik's silicon-carbide stent coating and Avontec's new material designed to disrupt the restenosis process that often occurs following angioplasty.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies